AMGEN TECHNOLOGY (IRELAND) UNLIMITED COMPANY

Amgen Technology (Ireland) Unlimited Company is the Irish arm of a global biotechnology leader that pioneers the use of living cells to create biologic medicines. By harnessing cutting-edge science and advanced technologies, Amgen develops treatments for serious illnesses where therapeutic options are often limited, delivering innovative therapies that improve patients' lives worldwide.

The company's portfolio spans a range of biologic products that address conditions such as cardiovascular disease, bone health, asthma, chronic rhinosinusitis and various cancers. Amgen also leverages artificial intelligence to streamline patient access and reimbursement, and it invests heavily in research and development, exemplified by its new $600 million Centre for Science and Innovation. Through initiatives like the Amgen Foundation's scholarship programme and partnerships with organisations such as the Los Angeles Sports & Entertainment Commission, the firm demonstrates a strong commitment to responsibility, quality and community impact.

Based in Ireland, Amgen Technology (Ireland) serves patients, healthcare professionals and research partners across the region, combining scientific excellence with a clear focus on delivering life-changing medicines.